Flagship explainer
How HALOZYME THERAPEUTICS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $1.4B | 100% |
| |
| Cost of revenue | $229M | 16% |
|
| $1.2B | 84% |
| |
| $469M | 34% |
| |
| Income before tax | $467M | 33% |
|
| Income tax | $150M | 11% |
|
| $317M | 23% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001159036-26-000024